Two Seas Capital LP
Source: SEC Form 13F · as of Mar 2026Two Seas Capital LP holds 10 biotech & pharma companies tracked by BioSniper, totaling $925.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$925.5M
| Company | Shares | Value |
|---|---|---|
| ROIVRoivant Sciences Ltd. | 10,060,591 | $278.7M |
| INDVIndivior Pharmaceuticals, Inc. | 4,746,510 | $144.7M |
| NKTRNEKTAR THERAPEUTICS | 1,959,178 | $141.0M |
| SHCSotera Health Company | 6,023,371 | $86.4M |
| ABUSArbutus Biopharma Corp | 18,557,543 | $83.5M |
| IMVTImmunovant, Inc. | 3,201,962 | $79.5M |
| MRNAModerna, Inc. | 1,100,000 | $55.9M |
| ESPREsperion Therapeutics, Inc. | 11,394,833 | $31.2M |
| QUREuniQure N.V. | 1,300,000 | $21.3M |
| LUCDLucid Diagnostics Inc. | 3,000,000 | $3.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.